Identifying type 2 diabetics with high coronary risk: role of the apo (a) polymorphism cut-off. C.Gazzaruso, A.Garzaniti, E.De Amici, P.Ferrari, P.Fratino. Trends Med 2003; 3(1):67-72
Design, methods and evaluation directions of a multi-access service for the management of diabetes mellitus patients. Bellazzi R, Arcelloni M, Bensa G, Blankenfeld H, Brugués E, Carson E, Cobelli C, Cramp D, D'Annunzio G, De Cata P, De Leiva A, Deutsch T, Fratino P, Gazzaruso C, Garcìa A, Gergely T, Gómez E, Harvey F, Ferrari P, Hernando E, Boulos MK, Larizza C, Ludekke H, Maran A, Nucci G, Pennati C, Ramat S, Roudsari A, Rigla M, Stefanelli M. Diabetes Technol Ther. 2003;5(4):621-9
Management of patients with diabetes through information technology: tools for monitoring and control of the patients' metabolic behavior. Bellazzi R, Arcelloni M, Ferrari P, Decata P, Hernando ME, García A, Gazzaruso C, Gómez EJ, Larizza C, Fratino P, Stefanelli M. Diabetes Technol Ther. 2004 Oct;6(5):567-78.
The M2DM Project-the experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients. Larizza C, Bellazzi R, Stefanelli M, Ferrari P, De Cata P, Gazzaruso C, Fratino P, D'Annunzio G, Hernando E, Gomez EJ. Methods Inf Med. 2006;45(1):79-84.
Unità di Cure palliative ospedaliere: nel pubblico come nel privato. Un modello possibile. Pietro Ferrari, Chiara Cornalba, Anna Giardini, Anna Cuomo, Riccardo Bellazzi, Pietro Preti. La Rivista Italiana di Cure Palliative, 2006; 4:60-64
Going mobile with a multiaccess service for the management of diabetic patients. Lanzola G, Capozzi D, D'Annunzio G, Ferrari P, Bellazzi R, Larizza C. J Diabetes Sci Technol. 2007 Sep;1(5):730-7
International Classification of Functioning, Disability and Health (ICF) e Qualità della Vita nel paziente oncologico in fase avanzata di malattia. Giardini A, Ferrari P, Majani G, Negri EM, Rossi S, Magnani C, Preti P. G Ital Med Lav Ergon 2010;32(3):B29-36.
Knowledge and expectations of patients in palliative care: issues regarding communication with people affected by life-threatening diseases. Giardini A, Giorgi I, Sguazzin C, Callegari S, Ferrari P, Preti P, Miotti D. G Ital Med Lav Ergon. 2011;33(1 Suppl A):A41-6.
Diabete in cure palliative: raccomandazioni SID-AMD e principali indicatori clinici. Dionisio R, Ferrari P, Negri E, Rossi S,De Cata P, Pirali B, Giardini A, Preti P. Il giornale di AMD, 2013.
Diabetes management in end-of-life: a preliminary report stemming from clinical experience. Dionisio R, Giardini A, De Cata P, Pirali B, Rossi S, Negri EM, Ferrari P, Preti P. Am J Hosp Pall Med, 2015 Sep;32(6):588-93.
Caregivers' positive role in old cancer patients' abilities at end of life: usefulness of the ICF framework. Giardini A, Ferrari P, Negri EM, Majani G, Magnani C, Preti P Eur J Phys Rehabil Med. 2015 Sep 10. [Epub ahead of print]
Lavori pubblicati come CPOR Study Group member:
Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients. Cancer Pain Outcome Research Study Group. Health Qual Life Outcomes. 2006 Feb 2;4:7.
A multidisciplinary project to improve the quality of cancer pain management in Italy: background, methods, and preliminary results. J Ambul Care Manage 2006 Oct-Dec;29(4):332-41.
Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 2009 May 19;100(10):1566-74. Epub 2009 Apr 28.
Effect of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group. Cancer Pain Outcome Research Study Group (CPOR SG) Investigators, Clin J Pain. 2009 Oct;25(8):671-82.
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. (List of collaborators); CERP STUDY OF PAIN GROUP. Ann Oncol. 2016 Jun;27(6):1107-15. doi: 10.1093/annonc/mdw097. Epub 2016 Mar 2
